1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 India Neurological Biomarkers Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 India Neurological Biomarkers Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 India Neurological Biomarkers Market - Breakup by Type
6.1 Genomic Biomarkers
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Forecast (2024-2032)
6.2 Proteomic Biomarkers
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Forecast (2024-2032)
6.3 Metabolomic Biomarkers
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2018-2023)
6.3.3 Market Forecast (2024-2032)
6.4 Imaging Biomarkers
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2018-2023)
6.4.3 Market Forecast (2024-2032)
6.5 Others
6.5.1 Historical and Current Market Trends (2018-2023)
6.5.2 Market Forecast (2024-2032)
7 India Neurological Biomarkers Market - Breakup by Application
7.1 Alzheimer's Disease
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Forecast (2024-2032)
7.2 Parkinson's Disease
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Forecast (2024-2032)
7.3 Multiple Sclerosis
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Forecast (2024-2032)
7.4 Autism Spectrum Disorders
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2018-2023)
7.4.3 Market Forecast (2024-2032)
7.5 Others
7.5.1 Historical and Current Market Trends (2018-2023)
7.5.2 Market Forecast (2024-2032)
8 India Neurological Biomarkers Market - Breakup by End Use
8.1 Hospital Laboratories
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Forecast (2024-2032)
8.2 Clinical Diagnostic Centers
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Forecast (2024-2032)
8.3 Research Organizations
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Forecast (2024-2032)
8.4 Others
8.4.1 Historical and Current Market Trends (2018-2023)
8.4.2 Market Forecast (2024-2032)
9 India Neurological Biomarkers Market – Breakup by Region
9.1 North India
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Breakup by Type
9.1.4 Market Breakup by Application
9.1.5 Market Breakup by End Use
9.1.6 Key Players
9.1.7 Market Forecast (2024-2032)
9.2 West and Central India
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Breakup by Type
9.2.4 Market Breakup by Application
9.2.5 Market Breakup by End Use
9.2.6 Key Players
9.2.7 Market Forecast (2024-2032)
9.3 South India
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2018-2023)
9.3.3 Market Breakup by Type
9.3.4 Market Breakup by Application
9.3.5 Market Breakup by End Use
9.3.6 Key Players
9.3.7 Market Forecast (2024-2032)
9.4 East and Northeast India
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2018-2023)
9.4.3 Market Breakup by Type
9.4.4 Market Breakup by Application
9.4.5 Market Breakup by End Use
9.4.6 Key Players
9.4.7 Market Forecast (2024-2032)
10 India Neurological Biomarkers Market – Competitive Landscape
10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant
11 Profiles of Key Players
11.1 Company A
11.1.1 Business Overview
11.1.2 Product Portfolio
11.1.3 Business Strategies
11.1.4 SWOT Analysis
11.1.5 Major News and Events
11.2 Company B
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Business Strategies
11.2.4 SWOT Analysis
11.2.5 Major News and Events
11.3 Company C
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Business Strategies
11.3.4 SWOT Analysis
11.3.5 Major News and Events
11.4 Company D
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Business Strategies
11.4.4 SWOT Analysis
11.4.5 Major News and Events
11.5 Company E
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Business Strategies
11.5.4 SWOT Analysis
11.5.5 Major News and Events
Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report.
12 India Neurological Biomarkers Market - Industry Analysis
12.1 Drivers, Restraints, and Opportunities
12.1.1 Overview
12.1.2 Drivers
12.1.3 Restraints
12.1.4 Opportunities
12.2 Porters Five Forces Analysis
12.2.1 Overview
12.2.2 Bargaining Power of Buyers
12.2.3 Bargaining Power of Suppliers
12.2.4 Degree of Competition
12.2.5 Threat of New Entrants
12.2.6 Threat of Substitutes
12.3 Value Chain Analysis
13 Appendix